Effects of Cangrelor as Adjunct Therapy to Percutaneous Coronary Intervention.

MLA

Hideo-Kajita, Alexandre, et al. “Effects of Cangrelor as Adjunct Therapy to Percutaneous Coronary Intervention.” The American Journal of Cardiology, vol. 123, no. 8, Apr. 2019, pp. 1228–38. EBSCOhost, https://doi.org/10.1016/j.amjcard.2019.01.031.

APA

Hideo-Kajita, A., Rogers, T., Buchanan, K., Iantorno, M., Gajanana, D., Ozaki, Y., Dan, K., Kolm, P., Brathwaite, E., Beyene, S., Melaku, G., Meirovich, Y., Dheendsa, A., Garcia-Garcia, H. M., Torguson, R., & Waksman, R. (2019). Effects of Cangrelor as Adjunct Therapy to Percutaneous Coronary Intervention. The American Journal of Cardiology, 123(8), 1228–1238. https://doi.org/10.1016/j.amjcard.2019.01.031

Chicago

Hideo-Kajita, Alexandre, Toby Rogers, Kyle Buchanan, Micaela Iantorno, Deepakraj Gajanana, Yuichi Ozaki, Kazuhiro Dan, et al. 2019. “Effects of Cangrelor as Adjunct Therapy to Percutaneous Coronary Intervention.” The American Journal of Cardiology 123 (8): 1228–38. doi:10.1016/j.amjcard.2019.01.031.